Need more? Try out  Advanced Search (20+ criteria)»

logo

Last Update

This profile was last updated on 5/16/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Kate Bingham?

Kate Bingham

Managing Partner

SV Life Sciences

HQ Phone:  (617) 367-8100

Direct Phone: +44 ** **** ****direct phone

Email: k***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

SV Life Sciences

One Boston Place 201 Washington Street

Boston, Massachusetts,02108

United States

Company Description

SV Life Sciences is a leading, international healthcare venture capital firm. SVLS affiliated funds have been investing in healthcare companies since the early 1980s and the Firm closed its first dedicated life sciences fund in 1994. SVLS' team of 35 professio... more

Find other employees at this company (70)

Background Information

Employment History

Position, Business Development

Vertex Pharmaceuticals Incorporated


Head of Technology Media and Telecoms Department

SNR Denton


Head of Technology Media and Telecoms Department

Denton Wilde Sapte LLP


Affiliations

Autifony Therapeutics Limited

Board Member


Calchan Limited

Board Member


Oxford University

Investment Committee Member of Spin-out Equity Management


Autifony Therapeutics Limited

Board Member


Kesios Therapeutics Limited

Board Member


Medcity

Advisory Board Member


Pulmocide LTD

Board Member


DDF

Investment Committee As Well As the Investment Committees for Al SV's Funds


Bicycle Therapeutics Limited

Board Member


MedCity Limited

ADVISORY BOARD Member


RespiVert LTD

Board Member


Affibody AB

Board Member


Trine Pharmaceuticals , Inc.

Board Member


Ingenium Pharmaceuticals GmbH

Member, Supervisory Board


Dynogen Pharmaceuticals , Inc.

Board Member


PowderMed Ltd

Board Member


Nexans SA

Board Member


Metris

Board Member


MedNova

Board Member


LeukoSite

Board Member


Hexagen

Board Member


British Venture Capital Association

Council Member


Cobra

Board Member


Education

MBA

Harvard Business School


Masters degree

Biochemistry

Oxford University


first class degree

Biochemistry

Oxford University


Web References(140 Total References)


SV Life Sciences Team

svlsm.com [cached]

Kate Bingham
Kate Bingham Managing Partner Kate Bingham joined SVLS in 1991. Kate currently serves or has served on the boards of companies in the UK, US, Ireland, Sweden and Germany. She has been responsible for past investments in Affinium, Alantos, Auxilium, Convergence, ESBATech, EUSA, Hexagen, Kinetix, KuDOS, Leukosite, MedNova, Micromet, Oncoethix, PowderMed, RespiVert and Vantia and current investments including Atopix, Autifony, Bicycle, Calchan, Kalvista, Karus, Pulmocide, TopiVert and VHSquared. Prior to joining SVLS, Kate worked in business development for Vertex Pharmaceuticals, a biotechnology company in Cambridge, MA and at Monitor Company, a strategy consulting firm. Kate has a first class degree in Biochemistry from Oxford University and graduated from Harvard Business School with an MBA.


The Board | Topivert

www.topivert.com [cached]

Before joining SVLS, Hamish was CEO of Cambridge Antibody Technology (CAT).
Kate Bingham (Observer) Kate is a Managing Partner at SV Life Sciences Advisers, LLC (SVLS). She has been responsible for many successful venture capital investments in biotechnology companies, since joining the firm in 1991. Kate currently serves as a Director of Autifony Therapeutics, Bicycle Therapeutics, Calchan and Convergence Pharmaceuticals. Previously, she worked in business development at Vertex Pharmaceuticals and at Monitor Company. She graduated from Harvard Business School with an MBA, where she was a Baker Scholar, and also holds a first class Masters degree in Biochemistry from the University Oxford.


SV Life Sciences - International Life Sciences Venture Capital Firm

www.svlsa.com [cached]

Kate Bingham
Kate Bingham Biotechnology


SV Life Sciences

www.svlsa.com [cached]

Kate Bingham


SV Life Sciences Team

www.svlsm.com [cached]

Kate Bingham represents SV Life Sciences Advisers LLP which provides unique deal flow for investment opportunities in unquoted investments.
Together Carl Harald, Kate and Ailsa sit on an investment committee to decide which investments to make in IBT in both public and private investments. Kate Bingham Kate Bingham


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory